PFIZER TO TRIAL NEW ONCE A DAY WEIGHT LOSS PILL
Photo Credit: Getty Images
Pharmaceutical giant Pfizer announced plans to advance a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year. This move follows the company's decision to discontinue the twice-daily version of the drug late last year due to high dropout rates in midstage trials caused by side effects such as nausea and vomiting.